These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 34557032)

  • 1. Comprehensive Analysis of the Prognostic Value and Immune Function of Immune Checkpoints in Stomach Adenocarcinoma.
    Shen K; Liu T
    Int J Gen Med; 2021; 14():5807-5824. PubMed ID: 34557032
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The circadian clock is associated with prognosis and immune infiltration in stomach adenocarcinoma.
    Huang Z; He A; Wang J; Lu H; Zhang R; Wu L; Feng Q
    Aging (Albany NY); 2021 Jun; 13(12):16637-16655. PubMed ID: 34162762
    [TBL] [Abstract][Full Text] [Related]  

  • 3. IRF7 is a Prognostic Biomarker and Associated with Immune Infiltration in Stomach Adenocarcinoma.
    Guo L; Fang T; Jiang Y; Liu D
    Int J Gen Med; 2021; 14():9887-9902. PubMed ID: 34938108
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification and Validation a Necroptosis‑related Prognostic Signature and Associated Regulatory Axis in Stomach Adenocarcinoma.
    Wang N; Liu D
    Onco Targets Ther; 2021; 14():5373-5383. PubMed ID: 34880629
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of RFX5 as prognostic biomarker and associated with immune infiltration in stomach adenocarcinoma.
    Guo L; Liu D
    Eur J Med Res; 2022 Aug; 27(1):164. PubMed ID: 36045400
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comprehensive analysis of the expression, prognostic, and immune infiltration for COL4s in stomach adenocarcinoma.
    Xu Y; Jin H; Chen Y; Yang Z; Xu D; Zhang X; Yang J; Wang Y
    BMC Med Genomics; 2024 Jun; 17(1):168. PubMed ID: 38907304
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Data mining combines bioinformatics discover immunoinfiltration-related gene SERPINE1 as a biomarker for diagnosis and prognosis of stomach adenocarcinoma.
    Zhai Y; Liu X; Huang Z; Zhang J; Stalin A; Tan Y; Zhang F; Chen M; Shi R; Huang J; Wu C; Wu Z; Lu S; You L; Wu J
    Sci Rep; 2023 Jan; 13(1):1373. PubMed ID: 36697459
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Toll-like receptor 3 is a potential prognosis marker and associated with immune infiltration in stomach adenocarcinoma.
    Huang Z; He A; Wang J; Lu H; Xu X; Zhang R; Liao W; Feng Q; Wu L
    Cancer Biomark; 2022; 34(1):77-93. PubMed ID: 34657879
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comprehensive Characterization of Transforming Growth Factor Beta Receptor 1 in Stomach Adenocarcinoma Identifies a Prognostic Signature for Predicting Clinical Outcomes and Immune Infiltrates.
    He Y; Zhang H; Zhang Y; Wang P; Zhu K; Ba Y
    Int J Gen Med; 2022; 15():3375-3391. PubMed ID: 35368798
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A ferroptosis-related gene in Helicobacter pylori infection, SOCS1, serves as a potential prognostic biomarker and corresponds with tumor immune infiltration in stomach adenocarcinoma: In silico approach.
    Yan P; Cheng M; Wang L; Zhao W
    Int Immunopharmacol; 2023 Jun; 119():110263. PubMed ID: 37156031
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differential genetic mutations and immune cell infiltration in high- and low-risk STAD: Implications for prognosis and immunotherapy efficacy.
    Deng YY; Sun Y; Wu SJ; Zhang TY; Yang J; Liu K
    J Cell Mol Med; 2024 Apr; 28(7):e18174. PubMed ID: 38494839
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of immune checkpoint inhibitors and biomarkers among STAT family in stomach adenocarcinoma.
    Guo L; Fang T; Jiang Y; Liu D
    Am J Transl Res; 2020; 12(9):4977-4997. PubMed ID: 33042401
    [No Abstract]   [Full Text] [Related]  

  • 13. High Endothelin Receptor Type A Expression as an Independent Prognostic Biomarker and Correlated with Immune Infiltrates in Stomach Adenocarcinoma.
    Yan Y; Nie K; Zheng J; Jiang X; Huang Y; Zheng Z; Wen Y; Li P
    Cancer Manag Res; 2021; 13():5013-5026. PubMed ID: 34234547
    [TBL] [Abstract][Full Text] [Related]  

  • 14. ASF1B acted as a prognostic biomarker for stomach adenocarcinoma.
    Zhao C; Zhou J; Xing J; Yin Q
    Medicine (Baltimore); 2023 Dec; 102(48):e35408. PubMed ID: 38050219
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CXCL2 acts as a prognostic biomarker and associated with immune infiltrates in stomach adenocarcinoma.
    Zhang J; Hou W; Zuo J; Huang Z; Ding X; Bu X
    Medicine (Baltimore); 2022 Oct; 101(42):e31096. PubMed ID: 36281171
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comprehensive Analysis and Identification of Prognostic Biomarkers and Therapeutic Targets Among FAM83 Family Members for Gastric Cancer.
    Zhang T; Lai S; Cai Y; Huang Z; Li Y; Chen S; Zhang Z; Ye Z; Lai X; Zhai E; Cai S; Chen J
    Front Cell Dev Biol; 2021; 9():719613. PubMed ID: 34869310
    [No Abstract]   [Full Text] [Related]  

  • 17. Comprehensive analysis of peroxisome proliferator-activated receptors to predict the drug resistance, immune microenvironment, and prognosis in stomach adenocarcinomas.
    Jia Q; Li B; Wang X; Ma Y; Li G
    PeerJ; 2024; 12():e17082. PubMed ID: 38529307
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Increased
    Zhaoran S; Linnebacher CS; Linnebacher M
    Cancers (Basel); 2023 Mar; 15(7):. PubMed ID: 37046730
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comprehensive analysis of expression signature and immune microenvironment signature of biomarker Endothelin Receptor Type A in stomach adenocarcinoma.
    Wang Z; Wang K; Yu X; Chen M; Du Y
    J Cancer; 2022; 13(7):2086-2104. PubMed ID: 35517422
    [No Abstract]   [Full Text] [Related]  

  • 20. Identification and characterization of a novel molecular classification incorporating oxidative stress and metabolism-related genes for stomach adenocarcinoma in the framework of predictive, preventive, and personalized medicine.
    Dong Y; Yuan Q; Ren J; Li H; Guo H; Guan H; Jiang X; Qi B; Li R
    Front Endocrinol (Lausanne); 2023; 14():1090906. PubMed ID: 36860371
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.